Caricamento...
In vitro and in vivo efficacy of a Rift Valley fever virus vaccine based on pseudovirus
Rift Valley fever virus (RVFV), a recognized category A priority pathogen, causes large outbreaks of Rift Valley fever with some fatalities in humans in humans and huge economic losses in livestock. As wild-type RVFV must be handled in BSL-3 or BSL-4 laboratories, we constructed a high-titer vesicul...
Salvato in:
| Pubblicato in: | Hum Vaccin Immunother |
|---|---|
| Autori principali: | , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6816429/ https://ncbi.nlm.nih.gov/pubmed/31170027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1627820 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|